EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma

Yongliang Lu, Weihao Chen, Yundong Xuan, Xiubin Li, Shengpan Wu, Hanfeng Wang, Tao Guo, Chenfeng Wang, Shuo Tian, Huaikang Li, Dong Lai, Wenlei Zhao und 7 weitere

Discover Oncology · 31.10.2024 · 15 (1)

DOI: 10.1007/s12672-024-01485-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 31.10.2024. Verfasst von Yongliang Lu und 18 weiteren Autor:innen. Beteiligte Einrichtung: People's Liberation Army Postgraduate Medical School, Fuxing Road 28, Haidian District, Beijing, 100853, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cells encounter unavoidable stress during tumor growth. The stress-induced transcription factor, activating transcription factor 4 (ATF4), has been reported to upregulate various adaptive genes involved in salvage pathways to alleviate stress and promote tumor progression. However, this effect is unknown in clear cell renal cell carcinoma (ccRCC). In this study, we found that ATF4 expression was remarkably upregulated in tumor tissues and associated with poor ccRCC outcomes. ATF4 depletion significantly impaired ccRCC cell proliferation, migration, and invasion in vitro and in vivo by inhibiting the AKT/mTOR and epithelial-mesenchymal transition (EMT)-related signaling pathway. RNA sequencing and functional studies identified nuclear protein 1 (NUPR1) as a key downstream target of ATF4 for repressing ferroptosis and promoting ccRCC cell survival. In addition, targeting ATF4 or pharmacological inhibition using NUPR1 inhibitor ZZW115 promoted antitumor immunity in syngeneic graft mouse models, represented by increased infiltration of CD4+ and CD8+ T cells. Furthermore, ZZW115 could improve the response to the PD-1 immune checkpoint blockade. The results demonstrate that the ATF4/NUPR1 signaling axis promotes ccRCC survival and facilitates tumor-mediated immunosuppression, providing a set of potential targets and prognostic indicators for ccRCC patients.

Schlagwörter

Stichwörter der Autor:innen

ATF4FerroptosisImmunosuppressionNUPR1ccRCC

Autor:innen und Institutionen

  • People's Liberation Army Postgraduate Medical School, Fuxing Road 28, Haidian District, Beijing, 100853, China.
  • State Key Laboratory of Kidney Diseases, Senior Department of Urology, The Third Medical Center of Chinese PLA General Hospital, Yongding Road 69, Haidian District, Beijing, 100039, China.
  • School of Medicine, Nankai University, Weijin Road 94, Tianjin, 300071, China.
  • State Key Laboratory of Kidney Diseases, Senior Department of Urology, The Third Medical Center of Chinese PLA General Hospital, Yongding Road 69, Haidian District, Beijing, 100039, China. urolancet@126.com.
  • State Key Laboratory of Kidney Diseases, Senior Department of Urology, The Third Medical Center of Chinese PLA General Hospital, Yongding Road 69, Haidian District, Beijing, 100039, China. dr.huangyan301@foxmail.com.
  • State Key Laboratory of Kidney Diseases, Senior Department of Urology, The Third Medical Center of Chinese PLA General Hospital, Yongding Road 69, Haidian District, Beijing, 100039, China. mxin301@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lu, Y., Chen, W., Xuan, Y., Li, X., Wu, S., Wang, H., Guo, T., Wang, C., Tian, S., Li, H., Lai, D., Zhao, W., Huang, X., Zhao, X., Wang, B., Zhang, X., Li, H., Huang, Y., & Ma, X. (2024). ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01485-0

Vancouver

Lu Y, Chen W, Xuan Y, Li X, Wu S, Wang H, et al. ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01485-0

BibTeX
@article{Lu2024,
  author = {Lu, Yongliang and Chen, Weihao and Xuan, Yundong and Li, Xiubin and Wu, Shengpan and Wang, Hanfeng and Guo, Tao and Wang, Chenfeng and Tian, Shuo and Li, Huaikang and Lai, Dong and Zhao, Wenlei and Huang, Xing and Zhao, Xupeng and Wang, Baojun and Zhang, Xu and Li, Hongzhao and Huang, Yan and Ma, Xin},
  title = {ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma},
  journal = {Discover Oncology},
  year = {2024},
  volume = {15},
  number = {1},
  doi = {10.1007/s12672-024-01485-0}
}
Kostenlos starten →